Navigation Links
Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services
Date:10/9/2009

LONDON, Oct. 9 /PRNewswire/ -- Private investment firm Czura Thornton today announced it has signed an agreement to acquire the global central laboratory ('GCL') operations of MDS Pharma Services, a business unit of MDS Inc (NYSE: MDZ; TSX: MDS).

GCL, to announce a new brand shortly, provides a comprehensive range of late-stage laboratory and electrocardiogram services supporting clinical trials globally. The business' proprietary leading edge Apollo CLPM(TM) (Central Lab Protocol Management) system offers clients real-time access to study data from around the world. GCL employs 600 people at accredited facilities in Beijing, Hamburg, North Brunswick (New Jersey), Paris, Singapore and Toronto.

In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to be acquiring MDS's global central laboratory platform and the deep expertise of the people there. Combined with our focus on the consistent delivery of high quality service and the flexibility and responsiveness that private ownership allows, we look forward to seeing renewed strength and growth in the business." They added that, "While we see excellent opportunities for collaboration with Chiltern, a leading CRO also owned by Czura Thornton, the two entities will operate independently."

The transaction is expected to close in the fourth quarter of 2009 and is subject to customary approvals and closing conditions. In addition, the sale of the Central Labs operations in France and Germany is subject to review and consultation with the applicable Works Councils in accordance with labor laws in those countries.

"We are pleased that the agreement with Czura Thornton creates opportunities to build the Central Labs business, which includes world-class facilities and highly skilled people focused on delivering superior client service," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc.

About Czura Thornton: Czura Thornton is a private investment group that was founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading CRO Chiltern (www.chiltern.com), has interests in the life sciences, international trade, property and automotive sectors. In particular Messrs Czura and Thornton have extensive international experience in the laboratory and CRO sectors. For further information see www.czurathornton.com.

Contact: Zareena Chattoo; +44 1753 216 611 (U.K.)

SOURCE Czura Thornton


'/>"/>
SOURCE Czura Thornton
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
2. Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation
3. NIAID announces vaccine adjuvant discovery contracts
4. STEMCELL Technologies Inc. Announces Direct Distribution to Spain
5. ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA
6. NCG Medical Announces Its Participation in Preliminary ARRA 2011 Certification Program
7. Institute for Liberty Announces the Launch of Keeping Small Business Healthy
8. PAREXEL Announces Date of First Quarter Fiscal Year 2010 Earnings Release and Conference Call
9. Medical Travel Company Satori World Medical Announces Relationship with Managing General Underwriter GreenWood International Insurance Services (GWI)
10. Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
11. Tranziger Announces Formation of Global Advisory & Development Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: